世界のネオアンチゲン標的療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Neoantigen Targeted Therapies Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5264
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、ネオアンチゲン標的療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（医療研究機関、病院・クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・ネオアンチゲン標的療法の市場動向
・企業の競争状況、市場シェア
・ネオアンチゲン標的療法の種類別市場規模と予測2016-2027（単剤療法、併用療法）
・ネオアンチゲン標的療法の用途別市場規模と予測2016-2027（医療研究機関、病院・クリニック、その他）
・ネオアンチゲン標的療法の北米市場規模2016-2027（アメリカ、カナダ）
・ネオアンチゲン標的療法の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・ネオアンチゲン標的療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ネオアンチゲン標的療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・ネオアンチゲン標的療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bavarian Nordic、Genocea Biosciences、Gradalis、Immunicum、Immunovative Therapies、Iovance Biotherapeutics、MediGene、Neon Therapeutics）
・結論

Recent developments in genomic analysis and advances in bioinformatics have enabled the adoption of more personalized treatment approaches, such as neoantigen targeted therapies. Cancer neoantigens is a term used to refer to a subset of antigens encoded by tumor-specific, mutated genes, which have not previously been recognized by the host’s immune system.

Market Analysis and Insights: Global Neoantigen Targeted Therapies Market
The global Neoantigen Targeted Therapies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neoantigen Targeted Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neoantigen Targeted Therapies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neoantigen Targeted Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neoantigen Targeted Therapies market.

Global Neoantigen Targeted Therapies Scope and Market Size
Neoantigen Targeted Therapies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neoantigen Targeted Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monotherapy
Combination Therapy

Segment by Application
Medical Research Institution
Hospital and Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bavarian Nordic
Genocea Biosciences
Gradalis
Immunicum
Immunovative Therapies
Iovance Biotherapeutics
MediGene
Neon Therapeutics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neoantigen Targeted Therapies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Neoantigen Targeted Therapies Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Medical Research Institution
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Neoantigen Targeted Therapies Market Perspective (2016-2027)
2.2 Neoantigen Targeted Therapies Growth Trends by Regions
2.2.1 Neoantigen Targeted Therapies Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neoantigen Targeted Therapies Historic Market Share by Regions (2016-2021)
2.2.3 Neoantigen Targeted Therapies Forecasted Market Size by Regions (2022-2027)
2.3 Neoantigen Targeted Therapies Industry Dynamic
2.3.1 Neoantigen Targeted Therapies Market Trends
2.3.2 Neoantigen Targeted Therapies Market Drivers
2.3.3 Neoantigen Targeted Therapies Market Challenges
2.3.4 Neoantigen Targeted Therapies Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Neoantigen Targeted Therapies Players by Revenue
3.1.1 Global Top Neoantigen Targeted Therapies Players by Revenue (2016-2021)
3.1.2 Global Neoantigen Targeted Therapies Revenue Market Share by Players (2016-2021)
3.2 Global Neoantigen Targeted Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neoantigen Targeted Therapies Revenue
3.4 Global Neoantigen Targeted Therapies Market Concentration Ratio
3.4.1 Global Neoantigen Targeted Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neoantigen Targeted Therapies Revenue in 2020
3.5 Neoantigen Targeted Therapies Key Players Head office and Area Served
3.6 Key Players Neoantigen Targeted Therapies Product Solution and Service
3.7 Date of Enter into Neoantigen Targeted Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Neoantigen Targeted Therapies Breakdown Data by Type
4.1 Global Neoantigen Targeted Therapies Historic Market Size by Type (2016-2021)
4.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Type (2022-2027)

5 Neoantigen Targeted Therapies Breakdown Data by Application
5.1 Global Neoantigen Targeted Therapies Historic Market Size by Application (2016-2021)
5.2 Global Neoantigen Targeted Therapies Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Neoantigen Targeted Therapies Market Size (2016-2027)
6.2 North America Neoantigen Targeted Therapies Market Size by Type
6.2.1 North America Neoantigen Targeted Therapies Market Size by Type (2016-2021)
6.2.2 North America Neoantigen Targeted Therapies Market Size by Type (2022-2027)
6.2.3 North America Neoantigen Targeted Therapies Market Size by Type (2016-2027)
6.3 North America Neoantigen Targeted Therapies Market Size by Application
6.3.1 North America Neoantigen Targeted Therapies Market Size by Application (2016-2021)
6.3.2 North America Neoantigen Targeted Therapies Market Size by Application (2022-2027)
6.3.3 North America Neoantigen Targeted Therapies Market Size by Application (2016-2027)
6.4 North America Neoantigen Targeted Therapies Market Size by Country
6.4.1 North America Neoantigen Targeted Therapies Market Size by Country (2016-2021)
6.4.2 North America Neoantigen Targeted Therapies Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Neoantigen Targeted Therapies Market Size (2016-2027)
7.2 Europe Neoantigen Targeted Therapies Market Size by Type
7.2.1 Europe Neoantigen Targeted Therapies Market Size by Type (2016-2021)
7.2.2 Europe Neoantigen Targeted Therapies Market Size by Type (2022-2027)
7.2.3 Europe Neoantigen Targeted Therapies Market Size by Type (2016-2027)
7.3 Europe Neoantigen Targeted Therapies Market Size by Application
7.3.1 Europe Neoantigen Targeted Therapies Market Size by Application (2016-2021)
7.3.2 Europe Neoantigen Targeted Therapies Market Size by Application (2022-2027)
7.3.3 Europe Neoantigen Targeted Therapies Market Size by Application (2016-2027)
7.4 Europe Neoantigen Targeted Therapies Market Size by Country
7.4.1 Europe Neoantigen Targeted Therapies Market Size by Country (2016-2021)
7.4.2 Europe Neoantigen Targeted Therapies Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Neoantigen Targeted Therapies Market Size (2016-2027)
8.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type
8.2.1 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2016-2027)
8.3 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application
8.3.1 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2016-2027)
8.4 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region
8.4.1 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Neoantigen Targeted Therapies Market Size (2016-2027)
9.2 Latin America Neoantigen Targeted Therapies Market Size by Type
9.2.1 Latin America Neoantigen Targeted Therapies Market Size by Type (2016-2021)
9.2.2 Latin America Neoantigen Targeted Therapies Market Size by Type (2022-2027)
9.2.3 Latin America Neoantigen Targeted Therapies Market Size by Type (2016-2027)
9.3 Latin America Neoantigen Targeted Therapies Market Size by Application
9.3.1 Latin America Neoantigen Targeted Therapies Market Size by Application (2016-2021)
9.3.2 Latin America Neoantigen Targeted Therapies Market Size by Application (2022-2027)
9.3.3 Latin America Neoantigen Targeted Therapies Market Size by Application (2016-2027)
9.4 Latin America Neoantigen Targeted Therapies Market Size by Country
9.4.1 Latin America Neoantigen Targeted Therapies Market Size by Country (2016-2021)
9.4.2 Latin America Neoantigen Targeted Therapies Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Neoantigen Targeted Therapies Market Size (2016-2027)
10.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type
10.2.1 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2016-2027)
10.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application
10.3.1 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2016-2027)
10.4 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country
10.4.1 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bavarian Nordic
11.1.1 Bavarian Nordic Company Details
11.1.2 Bavarian Nordic Business Overview
11.1.3 Bavarian Nordic Neoantigen Targeted Therapies Introduction
11.1.4 Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.1.5 Bavarian Nordic Recent Development
11.2 Genocea Biosciences
11.2.1 Genocea Biosciences Company Details
11.2.2 Genocea Biosciences Business Overview
11.2.3 Genocea Biosciences Neoantigen Targeted Therapies Introduction
11.2.4 Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.2.5 Genocea Biosciences Recent Development
11.3 Gradalis
11.3.1 Gradalis Company Details
11.3.2 Gradalis Business Overview
11.3.3 Gradalis Neoantigen Targeted Therapies Introduction
11.3.4 Gradalis Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.3.5 Gradalis Recent Development
11.4 Immunicum
11.4.1 Immunicum Company Details
11.4.2 Immunicum Business Overview
11.4.3 Immunicum Neoantigen Targeted Therapies Introduction
11.4.4 Immunicum Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.4.5 Immunicum Recent Development
11.5 Immunovative Therapies
11.5.1 Immunovative Therapies Company Details
11.5.2 Immunovative Therapies Business Overview
11.5.3 Immunovative Therapies Neoantigen Targeted Therapies Introduction
11.5.4 Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.5.5 Immunovative Therapies Recent Development
11.6 Iovance Biotherapeutics
11.6.1 Iovance Biotherapeutics Company Details
11.6.2 Iovance Biotherapeutics Business Overview
11.6.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Introduction
11.6.4 Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.6.5 Iovance Biotherapeutics Recent Development
11.7 MediGene
11.7.1 MediGene Company Details
11.7.2 MediGene Business Overview
11.7.3 MediGene Neoantigen Targeted Therapies Introduction
11.7.4 MediGene Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.7.5 MediGene Recent Development
11.8 Neon Therapeutics
11.8.1 Neon Therapeutics Company Details
11.8.2 Neon Therapeutics Business Overview
11.8.3 Neon Therapeutics Neoantigen Targeted Therapies Introduction
11.8.4 Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2016-2021)
11.8.5 Neon Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Neoantigen Targeted Therapies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Neoantigen Targeted Therapies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Neoantigen Targeted Therapies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Neoantigen Targeted Therapies Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Neoantigen Targeted Therapies Market Share by Regions (2016-2021)
Table 8. Global Neoantigen Targeted Therapies Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Neoantigen Targeted Therapies Market Share by Regions (2022-2027)
Table 10. Neoantigen Targeted Therapies Market Trends
Table 11. Neoantigen Targeted Therapies Market Drivers
Table 12. Neoantigen Targeted Therapies Market Challenges
Table 13. Neoantigen Targeted Therapies Market Restraints
Table 14. Global Neoantigen Targeted Therapies Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Neoantigen Targeted Therapies Market Share by Players (2016-2021)
Table 16. Global Top Neoantigen Targeted Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neoantigen Targeted Therapies as of 2020)
Table 17. Ranking of Global Top Neoantigen Targeted Therapies Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Neoantigen Targeted Therapies Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Neoantigen Targeted Therapies Product Solution and Service
Table 21. Date of Enter into Neoantigen Targeted Therapies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neoantigen Targeted Therapies Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Neoantigen Targeted Therapies Revenue Market Share by Type (2016-2021)
Table 25. Global Neoantigen Targeted Therapies Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Neoantigen Targeted Therapies Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Neoantigen Targeted Therapies Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Neoantigen Targeted Therapies Revenue Market Share by Application (2016-2021)
Table 29. Global Neoantigen Targeted Therapies Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Neoantigen Targeted Therapies Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Neoantigen Targeted Therapies Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Neoantigen Targeted Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Neoantigen Targeted Therapies Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Neoantigen Targeted Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Neoantigen Targeted Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Neoantigen Targeted Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Neoantigen Targeted Therapies Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Neoantigen Targeted Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Neoantigen Targeted Therapies Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Neoantigen Targeted Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Neoantigen Targeted Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Neoantigen Targeted Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Neoantigen Targeted Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Neoantigen Targeted Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Neoantigen Targeted Therapies Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Neoantigen Targeted Therapies Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Neoantigen Targeted Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Neoantigen Targeted Therapies Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Neoantigen Targeted Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Neoantigen Targeted Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Neoantigen Targeted Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Neoantigen Targeted Therapies Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Neoantigen Targeted Therapies Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Neoantigen Targeted Therapies Market Size by Country (2022-2027) & (US$ Million)
Table 61. Bavarian Nordic Company Details
Table 62. Bavarian Nordic Business Overview
Table 63. Bavarian Nordic Neoantigen Targeted Therapies Product
Table 64. Bavarian Nordic Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million)
Table 65. Bavarian Nordic Recent Development
Table 66. Genocea Biosciences Company Details
Table 67. Genocea Biosciences Business Overview
Table 68. Genocea Biosciences Neoantigen Targeted Therapies Product
Table 69. Genocea Biosciences Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million)
Table 70. Genocea Biosciences Recent Development
Table 71. Gradalis Company Details
Table 72. Gradalis Business Overview
Table 73. Gradalis Neoantigen Targeted Therapies Product
Table 74. Gradalis Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million)
Table 75. Gradalis Recent Development
Table 76. Immunicum Company Details
Table 77. Immunicum Business Overview
Table 78. Immunicum Neoantigen Targeted Therapies Product
Table 79. Immunicum Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million)
Table 80. Immunicum Recent Development
Table 81. Immunovative Therapies Company Details
Table 82. Immunovative Therapies Business Overview
Table 83. Immunovative Therapies Neoantigen Targeted Therapies Product
Table 84. Immunovative Therapies Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million)
Table 85. Immunovative Therapies Recent Development
Table 86. Iovance Biotherapeutics Company Details
Table 87. Iovance Biotherapeutics Business Overview
Table 88. Iovance Biotherapeutics Neoantigen Targeted Therapies Product
Table 89. Iovance Biotherapeutics Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million)
Table 90. Iovance Biotherapeutics Recent Development
Table 91. MediGene Company Details
Table 92. MediGene Business Overview
Table 93. MediGene Neoantigen Targeted Therapies Product
Table 94. MediGene Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million)
Table 95. MediGene Recent Development
Table 96. Neon Therapeutics Company Details
Table 97. Neon Therapeutics Business Overview
Table 98. Neon Therapeutics Revenue in Neoantigen Targeted Therapies Business (2016-2021) & (US$ Million)
Table 99. Neon Therapeutics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neoantigen Targeted Therapies Market Share by Type: 2020 VS 2027
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global Neoantigen Targeted Therapies Market Share by Application: 2020 VS 2027
Figure 5. Medical Research Institution Case Studies
Figure 6. Hospital and Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Neoantigen Targeted Therapies Report Years Considered
Figure 9. Global Neoantigen Targeted Therapies Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Neoantigen Targeted Therapies Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Neoantigen Targeted Therapies Market Share by Regions: 2020 VS 2027
Figure 12. Global Neoantigen Targeted Therapies Market Share by Regions (2022-2027)
Figure 13. Global Neoantigen Targeted Therapies Market Share by Players in 2020
Figure 14. Global Top Neoantigen Targeted Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neoantigen Targeted Therapies as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Neoantigen Targeted Therapies Revenue in 2020
Figure 16. Global Neoantigen Targeted Therapies Revenue Market Share by Type (2016-2021)
Figure 17. Global Neoantigen Targeted Therapies Revenue Market Share by Type (2022-2027)
Figure 18. North America Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Neoantigen Targeted Therapies Market Share by Type (2016-2027)
Figure 20. North America Neoantigen Targeted Therapies Market Share by Application (2016-2027)
Figure 21. North America Neoantigen Targeted Therapies Market Share by Country (2016-2027)
Figure 22. United States Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Neoantigen Targeted Therapies Market Share by Type (2016-2027)
Figure 26. Europe Neoantigen Targeted Therapies Market Share by Application (2016-2027)
Figure 27. Europe Neoantigen Targeted Therapies Market Share by Country (2016-2027)
Figure 28. Germany Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Neoantigen Targeted Therapies Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Neoantigen Targeted Therapies Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Neoantigen Targeted Therapies Market Share by Region (2016-2027)
Figure 38. China Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Neoantigen Targeted Therapies Market Share by Type (2016-2027)
Figure 46. Latin America Neoantigen Targeted Therapies Market Share by Application (2016-2027)
Figure 47. Latin America Neoantigen Targeted Therapies Market Share by Country (2016-2027)
Figure 48. Mexico Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Neoantigen Targeted Therapies Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Neoantigen Targeted Therapies Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Neoantigen Targeted Therapies Market Share by Country (2016-2027)
Figure 54. Turkey Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Neoantigen Targeted Therapies Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bavarian Nordic Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021)
Figure 58. Genocea Biosciences Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021)
Figure 59. Gradalis Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021)
Figure 60. Immunicum Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021)
Figure 61. Immunovative Therapies Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021)
Figure 62. Iovance Biotherapeutics Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021)
Figure 63. MediGene Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021)
Figure 64. Neon Therapeutics Revenue Growth Rate in Neoantigen Targeted Therapies Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2021-2027
QFJ1-3893 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、B細胞成熟抗原（BCMA）標的療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（二重特異性抗体、抗体薬物複合体、キメラ抗原受容体T細胞）、用途別市場規模（肝臓がん、呼吸器がん、脳腫瘍、その他）、主要...

世界のネオアンチゲン癌ワクチン市場規模・現状・予測（2021年-2027年）

Global Neoantigen Cancer Vaccine Market Size, Status and Forecast 2021-2027
QFJ1-4561 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、ネオアンチゲン癌ワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（個人特定ワクチン、既製ネオワクチン）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の微生物叢治療市場規模・現状・予測（2021年-2027年）

Global Microbiome Therapies Market Size, Status and Forecast 2021-2027
QFJ1-5252 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、微生物叢治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バクテリア、真菌、ウイルス、その他）、用途別市場規模（試験所、研究所、園芸、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の注射式標的治療市場規模・現状・予測（2021年-2027年）

Global Injectable Targeted Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4374 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、注射式標的治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、小分子、免疫毒素、その他）、用途別市場規模（病院、在宅医療、専門クリニック、その他）、主要地域別市場規模（北米、アメリ...

世界の睡眠時無呼吸症治療市場規模・現状・予測（2021年-2027年）

Global Sleep Apnea Therapies Market Size, Status and Forecast 2021-2027
QFJ1-4871 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、睡眠時無呼吸症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、手術、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の先進端細胞治療市場規模・現状・予測（2021年-2027年）

Global Advanced Cell Therapies Market Size, Status and Forecast 2021-2027
QFJ1-3769 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、先進端細胞治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（幹細胞移植、CART細胞療法）、用途別市場規模（幹細胞、再生医療）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界の抗ウイルス併用療法市場規模・現状・予測（2021年-2027年）

Global Antiviral Combination Therapies Market Size, Status and Forecast 2021-2027
QFJ1-3843 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、抗ウイルス併用療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NRTI / NNRTI、インテグラーゼ阻害剤/ NRTI、NRTI /プロテアーゼ阻害剤、その他）、用途別市場規模（HIV、肝炎、そ...

世界の卵巣癌治療＆診断市場規模・現状・予測（2021年-2027年）

Global Therapies and Diagnostics for Ovarian Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4951 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、卵巣癌治療＆診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（手術、放射線療法、薬物治療）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国...

世界の標的バイオマーカー市場規模・現状・予測（2021年-2027年）

Global Targeted Biomarker Market Size, Status and Forecast 2021-2027
QFJ1-4933 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、標的バイオマーカーの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（安全性バイオマーカー、有効性バイオマーカー、検証バイオマーカー）、用途別市場規模（診断開発、創薬・開発、個別化医療、疾病リスク評価、そ...

世界の標的化デリバリードラッグ市場規模・現状・予測（2021年-2027年）

Global Targeted Delivery Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4934 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、標的化デリバリードラッグの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（眼用ドラッグデリバリー、肺のドラッグデリバリー、薬剤溶出ステント、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市...

世界のB細胞成熟抗原（BCMA）標的療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market The global B-Cell Maturation Antigen(BCMA) Targeted Therapies market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standar…
世界のネオアンチゲン癌ワクチン市場規模・現状・予測（2021年-2027年） It is through the use of tumor cell-associated antigens to awaken the body's immune system against cancer. Market Analysis and Insights: Global Neoantigen Cancer Vaccine Market The global Neoantigen Cancer Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020,…
B細胞成熟抗原（BCMA）標的療法のグローバル市場調査 2019年 The global B-Cell Maturation Antigen(BCMA) Targeted Therapies market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on B-Cell Maturation Antigen(BCMA) Targeted Therapies volume and value at global level, reg…
世界の抗ウイルス併用療法市場規模・現状・予測（2021年-2027年） The triple combination of lopinavir-ritonavir, ribavirin, and interferon beta-1b holds promising potentials in the treatment of coronavirus (COVID-19). Researchers in healthcare companies and organizations are referring historical findings of the lopinavir-ritonavir & ribavirin combination, which wa…
世界の注射式標的治療市場規模・現状・予測（2021年-2027年） It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Wi…